TOP TIERMARKET NEWSWIRE
News & sentiment

CRISPR THERAPEUTICS (CRSP) — News & AI sentiment

CRISPR THERAPEUTICS (CRSP) news roundup. 2 stories in the past week, 14 over 30 days. Average 30-day sentiment is 64.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $211K — net selling of $211K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 67.5/100
30d stories
14
avg sentiment 64.6/100
Insider net (90d)
$211K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on CRSP

5d ago
Jul 22
Jul 22
Citizens reiterates CRISPR Therapeutics stock rating on pipeline progress
Investing.com Analyst Ratings56 · neutralanalyst
Jul 22
Jul 21
Jul 16
3 Reasons to Buy CRISPR Therapeutics Stock
The Motley Fool63 · neutralanalyst
Jul 10
Jul 8
Jul 7
Jul 7
Jul 7
Jul 6
Jul 3
Jul 2
Jun 29
Jun 27
Jun 18
Jun 9
Jun 8
Jun 8
Jun 6
Jun 4
Jun 4
Jun 3
Jun 1
Open CRSP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →